Manufacturing & Portfolio

Precision peptide manufacturing, built to the same standard as everything we bring to clinic

Vector Science & Therapeutics is building a dedicated cGMP peptide manufacturing and quality-testing capability to supply the orthopedic, sports medicine, and regenerative medicine channels with rigor, verified quality, and disciplined third-party distribution.

Development-Stage cGMP Manufacturing Third-Party Distribution
Our Business Model

Manufacturing,
Not Dispensing

Vector's peptide business is a manufacturing and supply model: we produce peptides for physicians and their patients across sports, regenerative, and longevity medicine channels.

Every batch is manufactured cGMP by a US-based, FDA-licensed contract development and manufacturing organization (CDMO), with an accompanying certificate of analysis for every lot. Independent quality and analytical testing (purity, potency, and consistency) is provided by Verlytix, Vector's dedicated related-company testing division.

Vector does not dispense peptides directly to patients.

cGMP Manufacturing

Produced by a US-based, FDA-licensed CDMO.

Verified Quality

Independent certificate of analysis on every lot.

Scaling Capacity

Multi-suite manufacturing coming online through 2026.

Third-Party Supply

Built for distributors, not direct-to-patient dispensing.

cGMP peptide manufacturing cleanroom with a stainless-steel process line and an open lyophilizer holding shelves of vials
Manufacturing Capacity

Built for Scale.
Setting the Standard.

Multi-suite cGMP manufacturing coming online through 2026, produced by a US-based, FDA-licensed CDMO, with an independent certificate of analysis accompanying every lot.

cGMP
US-Based, FDA-Licensed
100%
Lots With CoA
2026
Multi-Suite Online
Our Manufacturing Standard

One Discipline, Applied Everywhere

Peptide quality and supply are governed by the same discipline Vector applies across every part of the business, with specific focus on rigorous process control, verified output, and a supply chain built to last.

01 · Control

Process Control

Manufacturing and quality protocols informed by rigorous process controls at every stage of production, not one-size batch production.

02 · Distribution

Qualified Distribution

A supply chain directed toward qualified, credentialed distribution partners in orthopedic, sports, and regenerative medicine channels — not general consumer sale.

03 · Capacity

Durable Capacity

Manufacturing capacity and quality infrastructure built to scale sustainably, supporting long-term supply relationships rather than one-off production runs.

Distributor Network

Where Our Distributor Network Is Focused

Vector is building a dedicated distributor network to support the peptide portfolio across three channels.

Orthopedic

Supporting musculoskeletal and joint-focused practices managing degenerative joint disease and soft tissue injury, including osteoarthritis.

0M+
Americans affected by osteoarthritis

Sports Medicine

Supporting high-performance clinical environments where soft tissue injury and recovery timelines drive practice decision-making.

Regenerative Medicine

Supporting practices focused on tissue-level intervention and recovery, consistent with Vector's broader musculoskeletal regeneration mission.

Quality Infrastructure

Verified at Every Step

From cGMP production to independent release testing, each lot follows a documented path before it reaches a qualified distribution partner.

cGMP Production
LyoGenesis Plus
Independent Testing
Verlytix
Certificate of Analysis
Every Lot
Quality Release
Purity · Potency · Consistency
Qualified Distributor
Credentialed Partners
HPLC autosampler needle positioned above rows of sample vials in an analytical testing laboratory
Quality & Analytical Testing

Verlytix

Verlytix is Vector's dedicated quality and analytical testing division, providing independent verification of purity, potency, and consistency across the peptide portfolio.

Purity Potency Consistency Independent CoA
Rows of lyophilized peptide vials with grey stoppers on a frosted lyophilizer shelf
Manufacturing & Lyophilization

LyoGenesis Plus

LyoGenesis Plus provides the manufacturing and lyophilization expertise behind Vector's peptide production, operating under cGMP, FDA, and ISO qualification standards — including Class 5 cleanroom validation, calibrated equipment, and documented SOPs.

cGMP FDA ISO Class 5 Cleanroom Documented SOPs
Learn About Verlytix Manufacturing Update
On Site

Inside the Facility

Laboratory and analytical space supporting Vector's peptide program, photographed on site.

Analytical laboratory at a Vector facility with chromatography instrumentation on the bench
Analytical Laboratory
Chromatography instrumentation for purity, potency, and consistency testing
Laboratory suite at a Vector facility with a fume hood, benchwork, and instrumentation
Laboratory Suite
Fume hood and benchwork supporting formulation and quality workflows

Photographs of Vector facilities. Manufacturing suites are coming online through 2026.

Regulatory & Development Status

Investigational — Not FDA Approved

All Vector peptide candidates are investigational and have not been approved by the FDA for any indication. Vector's peptide portfolio is in a development and early commercial-manufacturing stage; product availability, specifications, and indicated uses are not being publicly disclosed at this stage and are subject to change as manufacturing capacity, regulatory guidance, and distribution agreements evolve.

Request a Credentialed Briefing

Detailed portfolio specifications, manufacturing capacity, and distribution terms are available to qualified distributors, clinical partners, and institutional investors under appropriate engagement.

Request a Briefing Investor Relations